Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Press Release - Cipla ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Emerging Markets Index 15th Nov 2021 Schedule of Analyst Institutional Investor Meeting 15th Nov 2021 Allotment of 1,03,588 equity shares under ESOS 2013-A 13th Nov 2021 Update on the Definitive Agreement entered between Cipla Technologies LLC and Pulmatrix Inc. for development and commercialization of Pulmazole 09th Nov 2021 Update on intimations dated 13th November, 2018 and 8th February, 2019 on acquisition agreement entered between InvaGen Pharmaceuticals Inc. and Avenue Therapeutics Inc. 03rd Nov 2021 Schedule of Analyst Institutional Investor Meeting 01st Nov 2021 Allotment of 29,627 equity shares under ESOS 2013-A 29th Oct 2021 Grant of stock options and employee stock appreciation rights 26th Oct 2021 Intimation on Scheme of arrangement 26th Oct 2021 Outcome of Board Meeting – 26th October 2021 26th Oct 2021 Pagination First page first Previous page ‹ Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
